Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.74B
-
Number of holders
-
2007
-
Total 13F shares, excl. options
-
1.32B
-
Shares change
-
+880K
-
Total reported value, excl. options
-
$110B
-
Value change
-
+$66.7M
-
Put/Call ratio
-
0.94
-
Number of buys
-
809
-
Number of sells
-
-937
-
Price
-
$83.67
Significant Holders of ABBOTT LABORATORIES - Common Stock (ABT) as of Q3 2019
2,148 filings reported holding ABT - ABBOTT LABORATORIES - Common Stock as of Q3 2019.
ABBOTT LABORATORIES - Common Stock (ABT) has 2,007 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.32B shares
of 1.74B outstanding shares and own 75.86% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (150M shares), BlackRock Inc. (128M shares), Capital Research Global Investors (113M shares), STATE STREET CORP (72.6M shares), Capital International Investors (46M shares), WELLINGTON MANAGEMENT GROUP LLP (40.7M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (32M shares), NORTHERN TRUST CORP (26.3M shares), FMR LLC (26.3M shares), and GEODE CAPITAL MANAGEMENT, LLC (24.7M shares).
This table shows the top 2007 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.